RE: ‘Twas the month before science day.24 Jan 2023 10:22
Does make you wonder, clearly to they have no ammunition now. They constantly fail against the very well informed posters on this board. The FUD assault had absolutely no effect and they appear to have given up.
There is also nothing left to ramp until we get the details of the next escalation.
We know:
-Avacta are the first company to crack FAP targeting
-6 of 6 biopsies showed therapeutic levels of dox
-Twice the dose of dox showed NO cardiotoxicity
-All other side effects showed marked reduction.
Then there is:
- with the mechanism of pre|CISION proved TMAC will surely accelerate.
- Affixyell progressing to the clinic, gene therapy utilising affimers.
- Point bio, who are licensed to utilise pre|CISION in thier radiology treatment, CANSEEK must be very keen to progress knowing it works.
- LGChem continue work on Affimer PD-L1 inhibitors with Affimer XT a partnership that's been in place since 2018 and generates key stage license payments.
- Owning a profit making diagnostic division,. Perfectly set up to market the range of Affimer based diagnostic tools avacta are working on.